Targeting the Fas/FasL signaling pathway in cancer therapy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2012-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14728222.2011.628937PMID 22239437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineering death receptor ligands for cancer therapy.

  2013cited by this paper
• Understanding rituximab function and resistance: implications for tailored therapy.

  2011cited by this paper
• Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells.

  2011cited by this paper
• Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

  2011cited by this paper
• Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways

  2011cited by this paper
• Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.

  2011cited by this paper
• FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Epigenetics in cancer: what's the future?

  2011cited by this paper
• A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis.

  2011cited by this paper
• APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.

  2011cited by this paper
• Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.

  2011cited by this paper
• Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death

  2011cited by this paper
• Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).

  2011cited by this paper
• Effect of the histone deacetylase inhibitor SNDX‐275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases

  2011cited by this paper
• Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.

  2011cited by this paper
• Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.

  2011cited by this paper
• Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

  2011influential reference
• A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.

  2010cited by this paper
• Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.

  2010cited by this paper
• Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2

  2010cited by this paper
• Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.

  2010cited by this paper
• Microbial-based therapy of cancer: Current progress and future prospects

  2010cited by this paper
• Death receptors: targets for cancer therapy.

  2010cited by this paper
• Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway.

  2010cited by this paper
• In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts

  2010cited by this paper
• IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

  2010cited by this paper
• Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas.

  2010cited by this paper
• Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation

  2010influential reference
• The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer.

  2010cited by this paper
• Cisplatin augments FAS-mediated apoptosis through lipid rafts.

  2010cited by this paper
• Matrix Metalloproteinase Inhibitors

  2010cited by this paper
• Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.

  2010cited by this paper
• miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.

  2010cited by this paper
• Aerosol Therapy for the Treatment of Osteosarcoma Lung Metastases: Targeting the Fas/FasL Pathway and Rationale for the Use of Gemcitabine

  2010cited by this paper
• Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.

  2010cited by this paper
• Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.

  2010cited by this paper
• FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors

  2010influential reference
• MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand*

  2010cited by this paper
• Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis.

  2010cited by this paper
• The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.

  2010cited by this paper
• Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells

  2009influential reference
• Overcoming drug resistance by enhancing apoptosis of tumor cells.

  2009cited by this paper
• Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity

  2009cited by this paper
• The role of FasL and Fas in health and disease.

  2009influential reference
• Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95‐induced apoptosis

  2009cited by this paper
• Highly frequent anti‐idiotype antibody in cynomolgus monkeys developed against mouse‐derived regions of anti‐Fas antibody humanized by complementarity determining region grafting

  2009cited by this paper
• Combination of Human Fas (CD95/Apo-1) Ligand with Adriamycin Significantly Enhances the Efficacy of Antitumor Response

  2009cited by this paper
• Upregulation of miR-23a∼27a∼24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells

  2009cited by this paper
• Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication‐competent CD95L adenovirus

  2009cited by this paper
• Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin

  2009cited by this paper
• Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells

  2009cited by this paper
• The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin

  2009cited by this paper
• Novel role of thiadiazolidine derivatives in inducing cell death through Myc-Max, Akt, FKHR, and FasL pathway.

  2009cited by this paper
• Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

  2009cited by this paper
• Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand

  2008cited by this paper
• Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation

  2008cited by this paper
• Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

  2008cited by this paper
• Combination of Fasl and GM‐CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma

  2008influential reference
• Creating immune privilege: active local suppression that benefits friends, but protects foes

  2008cited by this paper
• Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.

  2008cited by this paper
• Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists.

  2008cited by this paper
• microRNAs and death receptors.

  2008influential reference
• Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma.

  2008cited by this paper
• Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.

  2008cited by this paper
• Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity1

  2008cited by this paper
• Paclitaxel (Taxol®)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L)

  2008cited by this paper
• Creating immune privilege: active local suppression that benefits friends, but protects foes

  2008cited by this paper
• The Fas Death Signaling Pathway Connecting Reactive Oxygen Species Generation and FLICE Inhibitory Protein Down-Regulation1

  2008cited by this paper
• Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L

  2007cited by this paper
• Activation of CD95L fusion protein prodrugs by tumor-associated proteases

  2007cited by this paper
• A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.

  2007cited by this paper
• Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

  2007cited by this paper
• Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

  2007influential reference
• Fas Receptor Clustering and Involvement of the Death Receptor Pathway in Rituximab-Mediated Apoptosis with Concomitant Sensitization of Lymphoma B Cells to Fas-Induced Apoptosis1

  2007cited by this paper
• From cancer immunosurveillance to cancer immunotherapy

  2007cited by this paper
• CTLA-4 · FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals1

  2007cited by this paper
• Phase 2 Study of ABT-510 in Patients with Previously Untreated Advanced Renal Cell Carcinoma

  2007cited by this paper
• An elaborate pathway required for Ras-mediated epigenetic silencing

  2007cited by this paper
• ‘Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions’

  2007cited by this paper
• SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

  2007cited by this paper
• Up‐regulation of Fas (CD95) expression in tumour cells in vivo

  2007cited by this paper
• Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells

  2007cited by this paper
• Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

  2006cited by this paper
• A CD40–CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95

  2006cited by this paper
• A Fas agonist induces high levels of apoptosis in haematological malignancies.

  2006cited by this paper
• An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy

  2006cited by this paper
• Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report

  2006cited by this paper
• Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma

  2006cited by this paper
• Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

  2006cited by this paper
• Targeted induction of apoptosis for cancer therapy

  2006cited by this paper
• Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer

  2006cited by this paper
• A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells.

  2006cited by this paper
• CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.

  2006cited by this paper
• Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.

  2006cited by this paper
• Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals

  2005cited by this paper
• Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP

  2005cited by this paper
• Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.

  2005influential reference
• Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

  2005cited by this paper
• Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells

  2004cited by this paper

• Diagnostic Value of miR-1225-5p in Acute Coronary Syndrome and its Mechanism in ox-LDL Induced Human Coronary Artery Endothelial Cells Injury.

  2026cites this paper
• Kindlin-2 silencing promoted apoptosis and cell cycle arrest through the fas/FasL pathway in hepatocellular carcinoma

  2025cites this paper
• Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment

  2025cites this paper
• Small molecule agents against alopecia: Potential targets and related pathways.

  2024cites this paper
• Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma.

  2024cites this paper
• Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives

  2024cites this paper
• The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology.

  2024cites this paper
• Himalayan flora: targeting various molecular pathways in lung cancer

  2023cites this paper
• Analysis of Single-Cell RNA Sequencing Data Unveils Novel Immune Prognostic Biomarkers

  2023cites this paper
• Regulation of the tumor immune microenvironment by cancer-derived circular RNAs

  2023cites this paper
• A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

  2023cites this paper
• Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis

  2023cites this paper
• Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes

  2022cites this paper
• Fas and Fas ligand are highly expressed in lymphocytes from cervical intraepithelial neoplasia and cervical cancer patients: A possible role for immune escaping

  2022cites this paper
• Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy

  2022cites this paper
• Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue

  2022influential citation
• Vesicle Induced Receptor Sequestration: Mechanisms behind Extracellular Vesicle‐Based Protein Signaling

  2022cites this paper
• The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment

  2022cites this paper
• Agents Targeting Apoptosis Take Center Stage in the Battle against Cancer

  2022cites this paper
• Receptor Specificity Engineering of TNF Superfamily Ligands

  2022cites this paper
• Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects

  2022cites this paper
• Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism—A Review

  2022cites this paper
• Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

  2022cites this paper
• IRF8: Mechanism of Action and Health Implications

  2022cites this paper
• Regulated cell death (RCD) in cancer: key pathways and targeted therapies

  2022cites this paper
• ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies

  2022cites this paper
• Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression

  2021cites this paper
• Proteomic Alterations in Multiple Myeloma: A Comprehensive Study Using Bone Marrow Interstitial Fluid and Serum Samples

  2021cites this paper
• The anti-ovarian carcinoma activity of L-amino Acid Oxidase from Crotalus adamanteus venom in vivo and in vitro

  2021cites this paper
• Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma

  2021cites this paper
• Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures.

  2021cites this paper
• Genomic variants in Fas-mediated apoptosis pathway predict a poor response to Platinum-based Chemotherapy for Chinese Gastric Cancer Patients

  2021cites this paper
• Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer

  2021cites this paper
• Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer.

  2021cites this paper
• Immuno-modulating Mediators of Colon Cancer as Immuno-therapeutic: Mechanism and Potential

  2021cites this paper
• Anticancer Potential of Polysaccharides

  2021cites this paper
• Kindlin-2 promoted the progression of keloids through the Smad pathway and Fas/FasL pathway.

  2021cites this paper
• Synergic radiosensitization of sinomenine hydrochloride and radioiodine on human papillary thyroid carcinoma cells

  2021cites this paper
• Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.

  2021cites this paper
• The investigation of the role of Fas and FasL molecules in the extrinsic pathway of apoptosis as a target for cancer therapy in colorectal cancer

  2021cites this paper
• The Fas/FasL pathway as a target for enhancing anticancer adoptive cell therapy

  2021cites this paper
• 174 An ex vivo tumoroid model of fresh patient tumors (3D-ACT) to assess efficacy of cellular therapy in immuno-oncology

  2020cites this paper
• Effect and Molecular Mechanisms of Traditional Chinese Medicine on Tumor Targeting Tumor-Associated Macrophages

  2020cites this paper
• Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma

  2020cites this paper
• In silico analysis of the prognostic value of FAS mRNA in malignancies

  2020cites this paper
• A SEVERE CYTOKINE RELEASE SYNDROME WITH RESPIRATORY FAILURE IN RECURRENT MESOTHELIOMA INDUCED BY EPCAM CAR-T CELLS INFUSION: A CASE REPORT

  2020cites this paper
• DDDT_A_223646 907..919

  2020cites this paper
• Hesperetin upregulates Fas/FasL expression and potentiates the antitumor effect of 5-fluorouracil in rat model of hepatocellular carcinoma

  2020cites this paper
• A SEVERE CYTOKINE RELEASE SYNDROME WITH RESPIRATORY FAILURE IN RECURRENT MESOTHELIOMA INDUCED BY EPCAM CAR-T CELLS INFUSION: A CASE REPORT

  2020cites this paper
• Sensitization to cell death induced by soluble Fas ligand and agonistic antibodies with exogenous agents: A review

  2020cites this paper
• WNT–β-catenin signalling — a versatile player in kidney injury and repair

  2020cites this paper
• A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy

  2020cites this paper
• Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses

  2020cites this paper
• Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies

  2020cites this paper
• A novel synthetic chitosan selenate (CS) induces apoptosis in A549 lung cancer cells via the Fas/FasL pathway.

  2020cites this paper
• S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

  2019cites this paper
• Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.

  2019cites this paper
• Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer

  2019cites this paper
• In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells

  2019cites this paper
• Survivin Impairs the Apoptotic Machinery in CD4+ T Cells of Patients with Ulcerative Colitis

  2019cites this paper
• Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC.

  2019cites this paper
• Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U-2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis

  2019cites this paper
• Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells.

  2019cites this paper
• MULTIPLE BIOACTIVE COMPOUNDS OF Sambucus PLANT PROMOTE DEATH CELL SIGNALING PATHWAY VIA FAS RECEPTOR

  2019cites this paper
• Mechanisms and relevant genes of drug resistance in gastric cancer

  2018cites this paper
• SRSF7 knockdown promotes apoptosis of colon and lung cancer cells

  2018cites this paper
• 6991 Study of FasL IVS2nt-124A/G Polymorphism in Breast Cancer

  2018cites this paper
• Multi‐Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells

  2018cites this paper
• Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer

  2018cites this paper
• The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update

  2018cites this paper
• Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy

  2018cites this paper
• Mechanizmy imunitného systému v boji proti nádorom a príčiny ich zlyhania

  2018cites this paper
• Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer

  2018cites this paper
• Matrix Metalloproteinases-7 and Kidney Fibrosis

  2017cites this paper
• Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients

  2017cites this paper
• D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway

  2017cites this paper
• Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral load.

  2017cites this paper
• Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma

  2017cites this paper
• Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.

  2017cites this paper
• A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio

  2017cites this paper
• Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells

  2017cites this paper
• Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.

  2017cites this paper
• Study of FasL IVS2nt-124A/G Polymorphism in Breast Cancer Patients

  2017cites this paper
• Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer

  2017cites this paper
• Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis

  2017cites this paper
• Site-specific chemical conjugation of human Fas ligand extracellular domain using trans-cyclooctene – methyltetrazine reactions

  2017cites this paper
• Characterization and Potential Antitumor Activity of Polysaccharide from Gracilariopsis lemaneiformis

  2017cites this paper
• Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression

  2017cites this paper
• Apoptosis mediated chemosensitization of tumor cells to 5-fluorouracil on supplementation of fish oil in experimental colon carcinoma

  2017cites this paper
• Investigation of cadmium-induced apoptosis and the protective effect of N-acetylcysteine in BRL 3A cells.

  2016cites this paper
• Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma

  2016cites this paper
• White Adipose Tissue Browning: A Double-edged Sword.

  2016cites this paper
• Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation

  2016influential citation
• Interplay between Tumor Microenvironment and Cancer Cells

  2016cites this paper
• FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders

  2016cites this paper
• Significant association between FasL gene -844T/C polymorphism and risk to hepatocellular carcinoma in Egyptian patients.

  2016cites this paper
• Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression.

  2016cites this paper
• Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells

  2016cites this paper
• Strong Linkage Disequilibrium Between -670 A>G and -1377 G>A Polymorphisms in FAS Gene in Patients with Breast Cancer and Controls

  2016cites this paper
• Correlations of circulating levels of oxidants, antioxidants and soluble Fas in breast cancer among Egyptian females

  2016cites this paper